Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Claudia Sampor"'
Autor:
Scott Howard, Ryan Combs, Jennifer Lowe, Carmelo Rizzari, María Dolores Aumente, Pere Barba Suñol, Thais Murciano, Margarita Satostegui, Claudia Sampor, Nicolás Tentoni
Publikováno v:
HemaSphere, Vol 7, p e41684d5 (2023)
Externí odkaz:
https://doaj.org/article/1e4c30815c5043eb8181be89ee24e65b
Autor:
Gabriela Villanueva, Martin Guscott, Paula Schaiquevich, Claudia Sampor, Ryan Combs, Nicolás Tentoni, Miriam Hwang, Jennifer Lowe, Scott Howard
Publikováno v:
Cancers, Vol 15, Iss 5, p 1459 (2023)
Primary central nervous system lymphoma (PCNSL) is a highly aggressive non-Hodgkin lymphoma that is confined within the CNS. Due to its ability to cross the blood–brain barrier, high-dose methotrexate (HDMTX) is the backbone for induction chemother
Externí odkaz:
https://doaj.org/article/427771d9e7b5458a865ea6691931b159
Autor:
Rosario Aschero, Jasmine H. Francis, Daiana Ganiewich, Soledad Gomez-Gonzalez, Claudia Sampor, Santiago Zugbi, Daniela Ottaviani, Lauriane Lemelle, Marcela Mena, Ursula Winter, Genoveva Correa Llano, Gabriela Lamas, Fabiana Lubieniecki, Irene Szijan, Jaume Mora, Osvaldo Podhajcer, François Doz, François Radvanyi, David H. Abramson, Andrea S. Llera, Paula S. Schaiquevich, Cinzia Lavarino, Guillermo L. Chantada
Publikováno v:
Cancers, Vol 13, Iss 4, p 673 (2021)
Most reports about copy number alterations (CNA) in retinoblastoma relate to patients with intraocular disease and features of children with extraocular relapse remain unknown, so we aimed to describe the CNA in this population. We evaluated 23 patie
Externí odkaz:
https://doaj.org/article/f2e48227747f4fb38db89ad87d063a82
Autor:
Santiago Zugbi, Daiana Ganiewich, Arpita Bhattacharyya, Rosario Aschero, Daniela Ottaviani, Claudia Sampor, Eduardo G. Cafferata, Marcela Mena, Mariana Sgroi, Ursula Winter, Gabriela Lamas, Mariona Suñol, Manuel Daroqui, Edgardo Baialardo, Beatriz Salas, Anirban Das, Adriana Fandiño, Jasmine H. Francis, Fabiana Lubieniecki, Cinzia Lavarino, Ralph Garippa, Osvaldo L. Podhajcer, David H. Abramson, François Radvanyi, Guillermo Chantada, Andrea S. Llera, Paula Schaiquevich
Publikováno v:
Cancers, Vol 12, Iss 9, p 2714 (2020)
An uncommon subgroup of unilateral retinoblastomas with highly aggressive histological features, lacking aberrations in RB1 gene with high-level amplification of MYCN (MCYNamplRB1+/+) has only been described as intra-ocular cases treated with initial
Externí odkaz:
https://doaj.org/article/81557d201e1d47d68c9ae85fdabe680b
Autor:
Ursula Winter, Rosario Aschero, Federico Fuentes, Fabian Buontempo, Santiago Zugbi, Mariana Sgroi, Claudia Sampor, David H. Abramson, Angel M. Carcaboso, Paula Schaiquevich
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1077 (2019)
A preclinical model could aid in understanding retinoblastoma vitreous seeds behavior, drug penetration, and response to chemotherapy to optimize patient treatment. Our aim was to develop a tridimensional in vitro model of retinoblastoma vitreous see
Externí odkaz:
https://doaj.org/article/52d2cf96b3cd433393c4e2cae0828099
Autor:
Alejandra M. Scursoni, Laura Galluzzo, Sandra Camarero, Jessica Lopez, Fabiana Lubieniecki, Claudia Sampor, Valeria I. Segatori, Mariano R. Gabri, Daniel F. Alonso, Guillermo Chantada, María Teresa G. de Dávila
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
The N-glycolylated ganglioside NeuGc-GM3 has been described in solid tumors such as breast carcinoma, nonsmall cell lung cancer, and melanoma, but is usually not detected in normal human cells. Our aim was to evaluate the presence of NeuGc-GM3 in ped
Externí odkaz:
https://doaj.org/article/419bb88c1b654ec0941352d0469db38a
Autor:
Natalia Pinto, Nicolas Fernandez Ponce, Carlos Rugilo, Adriana Gonzalez, Fabiana Lubieniecki, Claudia Sampor, Daniel Alderete, Lorena V Baroni, Francisco R Maldonado, Candela Freytes, Agustina Oller
Publikováno v:
Journal of Neuro-Oncology. 155:53-61
Background Many studies have demonstrated in the last years that once medulloblastoma has recurred, the probability of regaining tumor control is poor despite salvage therapy. Although re-irradiation has an emerging role in other relapsed brain tumor
Autor:
Gabriela Villanueva, Claudia Sampor, Florencia Moreno, Daniel Alderete, Angelica Moresco, Natalia Pinto, Irene Szijan, Paula Schaiquevich, María Sara Felice, Adriana Rose, Pedro Zubizarreta, Mariana Sgroi, Adriana Fandiño, Guillermo Chantada
Publikováno v:
Pediatric Blood & Cancer. 69
Retinoblastoma survivors in low- and middle-income countries are exposed to high-intensity treatments that potentially place them at higher risk of early subsequent malignant neoplasms (SMNs).We followed 714 (403 [56.4%] nonhereditary and 311 [43.5%]
Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic
Autor:
Gabriela Villanueva, Claudia Sampor, Julia Palma, Milena Villarroel, Diana Valencia, Mercedes García Lombardi, Wendy Gomez Garcia, Eva Lezcano Caceres, Victoria Sobrero, Lilia Garcia, Victor Cabrera, Ivan Maza, Thelma Velasquez, Cecilia Ugaz, Jacqueline Montoya Vasquez, Rosdali Diaz Coronado, Natalia Gonzalez, Simone Aguiar, Agustin Dabezies, Florencia Moreno, Susan Sardinas, Yessika Gamboa, Essy Maradiegue, Ligia Fu, Pascale Gassant, Katiuska Moreno, Oscar Gonzales, Magdalena Schelotto, Sandra Luna‐Fineman, Celia Gianotti Antoneli, Soad Fuentes‐Alabi, Silvana Luciani, Andrea Cappellano, Guillermo Chantada, Liliana Vasquez
Publikováno v:
Pediatric bloodcancer. 69(10)
The ongoing coronavirus 2019 disease (COVID-19) pandemic strained medical systems worldwide. We report on the impact on pediatric oncology care in Latin American (LATAM) during its first year.Four cross-sectional surveys were electronically distribut
Autor:
Jasmine H. Francis, Maria Belen Cancela, Mariana Sgroi, Paula Schaiquevich, Claudia Sampor, Santiago Zugbi, Ana Laura Martinez, David H. Abramson, Ursula Winter, Guillermo Chantada, Ralph Garippa
Publikováno v:
Invest New Drugs
Intraocular retinoblastoma treatment has changed radically over the last decade, leading to a notable improvement in ocular survival. However, eyes that relapse remain difficult to treat, as few alternative active drugs are available. More challengin